Oxygenta Pharmaceutical Ltd — Important, 25-08-2025: Company Update

Oxygenta Pharmaceutical's board has approved reclassifying four shareholders, holding 9,42,700 equity shares (2.55% of total equity), from the Promoter Group to Public. This move, awaiting necessary approvals, aims to increase the company's public float. Additionally, the company announced significant leadership changes with the resignation of Mr. Vankineni Sai Sudhakar, its Managing Director and Chief Financial Officer, and Mr. Sanagari Kondal Reddy, an Independent Director. These departures are attributed to a change in company ownership and management. The board also re-constituted its committees and approved an upcoming Annual General Meeting for FY 2024-25.